Home » GSK to buy US cancer biotech Nuvalent for $10.6bn

GSK to buy US cancer biotech Nuvalent for $10.6bn

GSK to buy US cancer biotech Nuvalent for $10.6bn

This post was originally published on this site.


New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals